Diabetes Starter Pack — Glycomet SR 1000 + Glycomet-GP

📦 Varje beställning omfattas av vår Reshipment Assurance Policy — om din försändelse inte anländer inom 20 arbetsdagar, skickar vi om den.

Varför beställa från MedsBase

Våra generiska läkemedel kommer från WHO-GMP-certifierade tillverkare och skickas världsvidt i diskreta, enkla förpackningar — inget läkemedelsnamn på försändelsens utsida. Kortbetalningar hanteras via en reglerad betalningsprocessor (kontoutdrag visar en reglerad kortbetalningsprocessor — aldrig “MedsBase” eller något läkemedelsnamn). Krypto och SEPA-banköverföring accepteras också. Varje beställning backas upp av vår Reshipment Assurance Policy.

What’s in the Diabetes Starter Pack

• Glycomet SR 1000 mg (metformin hydrochloride sustained-release, USV India). First-line oral agent for type-2 diabetes per every major guideline since 1998. Mechanism: AMPK activation in liver suppresses hepatic gluconeogenesis (the dominant source of fasting hyperglycaemia in T2DM), with secondary effects on GLP-1, gut microbiome, and peripheral insulin sensitivity. The SR formulation halves the GI side-effect burden of immediate-release metformin.
• Glycomet-GP 500 mg + 2 mg (metformin + glimepiride). Adds a sulfonylurea — glimepiride binds the SUR1 subunit of pancreatic K-ATP channels and triggers insulin secretion. Used as the step-up second-line agent when HbA1c remains above target on metformin alone, particularly when SGLT-2 inhibitors or GLP-1 agonists are unavailable or unaffordable.

Why combine these two products?

For newly-diagnosed type-2 diabetes, the standard ADA/EASD pathway is: metformin first, escalate dose to 2000 mg/day over 4–8 weeks, recheck HbA1c at 12 weeks. If HbA1c remains above target (typically > 7%) and no specific compelling indication points to SGLT-2 / GLP-1 (no established ASCVD, CKD, or HF), a sulfonylurea like glimepiride is the most-used affordable second-line in many parts of the world.

This pack covers both the foundation regimen and the step-up regimen in one shipment. Patients who tolerate metformin well at 2000 mg/day can run on Glycomet SR alone (use the 6-month tier as a maintenance supply). Patients whose HbA1c remains elevated can step up by adding Glycomet-GP — typically replacing one of the metformin SR doses with the combination to keep total metformin dose roughly constant.

Who this pack is for

Best candidates:

• Adults newly diagnosed with type-2 diabetes (HbA1c 6.5–9.0%) starting first-line oral therapy
• Patients on metformin monotherapy whose HbA1c has not reached target after 12+ weeks at maximum tolerated dose
• Patients in regions where SGLT-2 inhibitors or GLP-1 receptor agonists are unavailable or unaffordable, where sulfonylureas remain the practical second-line
• Patients without ASCVD, HF, or CKD where the cardio-renal advantages of SGLT-2 / GLP-1 do not specifically apply

NOT appropriate for:

• Type-1 diabetes — requires insulin replacement, not insulin secretagogues
• HbA1c > 10% with hyperglycaemic symptoms — start insulin, not oral agents alone
• eGFR < 30 mL/min — metformin is contraindicated below this threshold (lactic acidosis risk)
• Acute illness, dehydration, contrast imaging within 48 hours — temporarily hold metformin
• Severe hepatic impairment (Child-Pugh B or C)
• Pregnancy — switch to insulin under specialist supervision; metformin may be continued in some PCOS-related pregnancy protocols only
• Heavy alcohol intake — raises lactic acidosis risk on metformin
• Known hypersensitivity to sulfonylureas (cross-reactivity with sulfa antibiotics)

How to use the pack correctly

Glycomet SR 1000 mg (metformin SR)

• Week 1–2: 500 mg (half a tablet, scored if possible — or use a 500 mg variant) once daily with the largest meal of the day.
• Week 3–4: 500 mg twice daily (or 1000 mg once daily with dinner).
• Week 5+: 1000 mg twice daily (target dose; some patients tolerate 2500 mg/day).
• Always take with food. SR formulation is once-daily preferred (with the evening meal); twice-daily is acceptable.
• Do not crush or chew the SR tablet — defeats the sustained-release matrix.

Glycomet-GP 500 mg + 2 mg (when stepping up)

• Start dose: 1 tablet with breakfast. Replaces one of the morning metformin SR doses to keep total metformin around 2000 mg/day.
• Titration: if HbA1c still above target after 8–12 weeks, increase to 1 tablet with breakfast and 1 tablet with dinner — but check fasting glucose and watch for hypoglycaemia.
• Take with food to reduce hypoglycaemia risk.
• Carry glucose tablets or sweetened juice if you drive, fast, or do prolonged exercise — sulfonylureas cause hypoglycaemia, metformin alone does not.

Combined-use safety

Combined metformin + glimepiride is well-studied — no clinically significant pharmacokinetic interaction. The combination has been a standard step-up regimen for 25+ years.

Watch for: B12 deficiency on long-term metformin (annual B12 check after 4+ years); contrast-imaging temporary hold (48 hours before and after IV contrast); alcohol limit of 1–2 drinks per occasion; weight changes (sulfonylureas modestly increase weight, metformin is weight-neutral); medication review at any new prescription (many drugs interact with sulfonylureas).

Monitoring schedule

Vanliga frågor

Is this the same as buying Glycomet SR and Glycomet-GP separately?

Exactly the same products — USV’s Glycomet SR 1000 mg and Glycomet-GP 500/2 mg, shipped together. The pack pricing is lower than buying each alone.

When should I add the Glycomet-GP component?

After 12 weeks at maximum tolerated metformin dose if HbA1c remains above your individualised target (typically > 7.0%). If your HbA1c has reached target on metformin alone, hold the Glycomet-GP in reserve — many patients do well on metformin monotherapy for years.

Why these two and not an SGLT-2 inhibitor or GLP-1?

SGLT-2 inhibitors (empagliflozin, dapagliflozin) and GLP-1 agonists (semaglutide, liraglutide) are clinically superior for patients with established cardiovascular disease, heart failure, or chronic kidney disease — they reduce major cardiovascular events independent of glucose lowering. For patients without those compelling indications, metformin + sulfonylurea remains a reasonable, affordable, and time-tested step-up. We stock SGLT-2 (Forxiga, Jardiance, Invokana) and GLP-1 (Ozempic, Mounjaro) options separately for patients who fit those indications.

Does metformin cause GI side effects?

Yes — diarrhoea, nausea, abdominal discomfort affect 20–30% of new starters. The SR formulation in this pack is specifically chosen because it halves the GI burden compared to immediate-release metformin. If side effects persist, slow the titration (stay at 500 mg/day for 2 weeks, then 500 BD for 2 weeks), always take with food, and consider splitting the dose.

Will I gain weight?

Metformin is weight-neutral or mildly weight-reducing. Glimepiride causes a modest 1–3 kg weight gain over 6–12 months on average (insulin-mediated, dose-related). For patients prioritising weight loss, an SGLT-2 inhibitor or GLP-1 is a better second-line.

Can I drink alcohol?

Limit to 1–2 standard drinks per occasion, with food. Heavy or binge drinking on metformin raises the (rare but serious) risk of lactic acidosis. Heavy drinking on glimepiride raises the risk of severe hypoglycaemia. Avoid drinking on an empty stomach.

What if I’m sick or stop eating for a day?

Hold both medications during acute illness with vomiting, severe diarrhoea, or significantly reduced food intake — “sick-day rules”. Resume when you are eating normally and well-hydrated. Severe hypoglycaemia from glimepiride during fasted illness is a real risk.

How will I know if my blood sugar is too low?

Symptoms of hypoglycaemia: sweating, shaking, hunger, racing heart, dizziness, confusion, slurred speech, vision change. Treat with 15 g of fast-acting carbohydrate (4–5 glucose tablets, half a glass of juice, 3 sugar lumps), recheck glucose in 15 minutes, repeat if < 4 mmol/L. Never drive while hypoglycaemic. Always carry glucose tablets once on glimepiride.

Can I pay with cryptocurrency?

Yes — Bitcoin, Ethereum, USDT and other major cryptocurrencies via Plisio with an automatic 10% discount at checkout. See the Guide för kryptobetalningar.

How is the pack shipped?

Discreet plain packaging with no drug names on the outside. Worldwide delivery. The Reshipment Assurance Policy covers a free reship if your parcel does not arrive within 20 business days.

What you get in each tier

Standard once-daily dosing for both tablets. Glycomet-GP supplies the glimepiride + metformin 500 mg combination tablet; Glycomet SR 1000 adds extended-release metformin to bring the total daily metformin to ≈1500 mg, the most common starting regimen for newly-diagnosed type 2 diabetes that has not responded to metformin monotherapy.

Also in our Diabetes Medication range

• Metformin alone: Glycomet SR, Biciphage 1000 SR
• Metformin + glimepiride combo alternatives: Glycomet-GP
• Metformin + glipizide combo: Glynase-MF
• SGLT-2 inhibitors (cardio-renal protective): Invokana
• DPP-4 inhibitors: see the full Diabetes Medication category
• GLP-1 agonists (Ozempic alternatives): see our Best Ozempic Alternatives 2026 guide

Important safety information

The Diabetes Starter Pack contains specialist-supervised medicines and should be used under medical supervision. Type-2 diabetes management requires regular HbA1c monitoring, renal function, and cardiovascular-risk assessment. Do not use metformin if eGFR < 30 mL/min, in severe hepatic impairment, or in active dehydration / acute illness. Hold metformin for 48 hours before and after IV contrast imaging. Glimepiride causes hypoglycaemia — always carry glucose tablets and notify a clinician if hypoglycaemic episodes are frequent. Do not use either drug in type-1 diabetes, in pregnancy without specialist guidance, or in known sulfonylurea hypersensitivity. Stop and seek emergency care for severe hypoglycaemia not corrected by oral carbohydrate, severe abdominal pain (lactic acidosis), jaundice, or any signs of severe hypersensitivity. This page is for educational purposes and does not replace consultation with a qualified clinician.

More options in Diabetes Medication

Rangerade efter senaste ordervolym på MedsBase — vad andra kunder i denna kategori väljer.

Glinate

US$13.00 – US$33.00Prijsbereik: US$13.00 tot US$33.00

Daonil

US$5.00 – US$12.00Prijsbereik: US$5.00 tot US$12.00

Glucobay

US$8.00 – US$31.00Prijsbereik: US$8.00 tot US$31.00